PATH, Coalition for Access to NCD Medicines and Products
Advancing access and financing for NCD medicines and products | UNGA80 Event Action Report
Report
20 Oct 2025
The availability, cost and affordability of essential medicines for asthma and COPD in LMIC: a systematic review, Lancet Global Health 2022
01 Oct 2022
This systematic review, commissioned by WHO, explored the availability, cost and affordability of essential medicines for asthma and COPD in LMICs in published literature between 2010-2022. Inhaled medicines were largely unavailable and unaffordable – this was particularly true for inhalers containing corticosteroids.
Related Resources
Union for International Cancer Control (UICC)
Policy Brief: Strengthening Equitable Access to Breast Cancer Care through National Health Policies
Briefs & Fact Sheets
13 Oct 2025
World Health Organization
Global report on hypertension 2025: high stakes: turning evidence into action
Report
23 Sep 2025
European Lung Foundation
Living with chronic respiratory disease: voices from around the world
Briefs & Fact Sheets
23 Sep 2025
PATH, Coalition for Access to NCD Medicines and Products
The case for investing better in noncommunicable diseases - even in times of crisis
Briefs & Fact Sheets
22 Sep 2025
Lancet Respiratory Medicine
Global epidemiology of chronic respiratory disease
Publication
22 Sep 2025